Monday, October 26, 2026 · Daily editionET --:--:--

Stopped early

Robotic Gait Rehabilitation in Parkinson's Disease

NCT05218187 · Indiana University · Updated 4 May 2026

What is being tested
G-EO End-Effector Gait Trainer; Conventional Physical Therapy Treatment
For
Parkinson Disease; Gait Disorder, Sensorimotor
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years and older. About 15 people. The full rules are on the registry page.
Where
United States
When
Starts or started 10 Jan 2022, ends 22 Aug 2025. Registered 1 Feb 2022.
Results
None posted yet.

In the researchers' words

The purpose of this study is to investigate the implementation of a novel gait rehabilitation stimulus (G-EO System) that could advance current clinical practices. The goal is to establish the safety and feasibility of gait training using the G-EO System as well as investigating the impact on mobility, function, quality of life, and participatory outcomes. Research Design: We propose a single-blinded, randomized trial of electromechanically-assisted gait training using the G-EO System in patients with Parkinson's disease with gait disability. Specific Aim 1 will establish the safety and feasibility of gait training using the G-EO System. Specific Aim 2 will determine the efficacy of gait training using the G-EO System for improving mobility, function, and quality of life
ClinicalTrials.gov, NCT05218187

Sites

  • IU Health Neurorehabilitation and RoboticsIndianapolis, Indiana, United States